# Gatehouse Bio, Inc. — Form D

Gatehouse Bio, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-15. The offering totals $5.4M, of which $5.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-01-15
- Form: D
- Accession: 0001840498-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.4M
- Amount sold: $5.4M
- Investors: 28
- Date of first sale: 2020-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-386501

## Issuer

- Name: Gatehouse Bio, Inc.
- CIK: 0001840498
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 35 Gatehouse Drive, WALTHAM, MA, 02451
- Phone: (339) 707-7763

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Neal W Foster | Director | Waltham, MA |
| David W Salzman, Ph.D. | Director | Waltham, MA |
| Neal W Foster | Executive Officer | Waltham, MA |
| David W Salzman, Ph.D. | Executive Officer | Waltham, MA |

## More

- [CIK 1840498 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1840498&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001840498-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.